Yunfei Lu
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Hepatology top 5%
Papers in
- Co-authors
- Xiaorong ChenZongguo YangWei ZhangZhenwei WangFeifei ChenQingnian XuBozong TangLiping Zhuang
- Journals
- Oncotarget (2 papers)Evidence-based Complementary and Alternative Medicine (2 papers)Medicine (2 papers)BioMed Research International (2 papers)International Journal of Medical Sciences (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Yunfei Lu
42 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 126
- Infectious Diseases 546
- Hepatology 133
- Complementary and alternative medicine 134
- Neurology 223
- Pharmacology 128
Countries citing papers authored by Yunfei Lu
This map shows the geographic impact of Yunfei Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunfei Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunfei Lu more than expected).
Fields of papers citing papers by Yunfei Lu
This network shows the impact of papers produced by Yunfei Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunfei Lu. The network helps show where Yunfei Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yunfei Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 5 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 6 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 1 | |
| 9 | 2021 | 36 | |
| 10 | 2021 | 7 | |
| 11 | 2020 | 66 | |
| 12 | 2020 | 27 | |
| 13 | 2020 | 30 | |
| 14 | 2019 | 21 | |
| 15 | 2017 | 32 | |
| 16 | 2016 | 1 | |
| 17 | 2015 | 138 | |
| 18 | 2013 | 13 | |
| 19 | 2013 | 18 | |
| 20 | 2008 | 4 |
About Yunfei Lu
Yunfei Lu is a scholar working on Hepatology, Pharmacology, Cancer Research, Complementary and alternative medicine and Infectious Diseases, having authored 45 papers that have together received 1.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (7 papers), COVID-19 Clinical Research Studies (6 papers), Ferroptosis and cancer prognosis (6 papers), Hepatitis B Virus Studies (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Ubiquitin and proteasome pathways (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Infectious Diseases (546 citations), Hepatology (133 citations), Complementary and alternative medicine (134 citations), Neurology (223 citations) and Pharmacology (128 citations). Yunfei Lu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xiaorong Chen, Zongguo Yang, Wei Zhang, Zhenwei Wang, Feifei Chen, Qingnian Xu, Xiaorong Chen, Bozong Tang, Liping Zhuang and Jia Shi. Their work appears in journals such as Oncotarget, Evidence-based Complementary and Alternative Medicine, Medicine, BioMed Research International and International Journal of Medical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.